OBJECTIVE: Recently, a strong association has been observed for the complement factor H (CFH) Tyr402His polymorphism with early and advanced age-related macular degeneration (AMD) in independent non-Hispanic White, clinic-based, case-control studies. These studies suggest the CFH His402 allele is a major risk allele in early and advanced AMD, explaining 43% to 70% of all AMD in older adults. We utilized a population-based case-control study design of early AMD among Latinos/Hispanics to evaluate the CFH Tyr402His polymorphism for an association with early AMD phenotypes. DESIGN: Retrospective population-based case-control study. PARTICIPANTS: This study cohort consists of 285 early AMD cases and 570 controls matched on age, birthplace, and smoking status. METHODS: Genotype determination was performed by allele-specific digestion of polymerase chain reaction products. MAIN OUTCOME MEASURES: Complement factor H Tyr402His polymorphism. RESULTS: We observed no overall statistically significant association with early AMD among Latinos. However, a subset of early AMD cases that have bilateral, not unilateral, intermediate-to-large soft macular drusen were 1.7 times more likely to carry either the homozygous or heterozygous His402 genotype. CONCLUSIONS: Our data suggest that the CFH Tyr402His is not a major risk factor for overall early AMD in this Latino population, but may play a role in susceptibility to phenotypes of early AMD likely to progress to late AMD.
OBJECTIVE: Recently, a strong association has been observed for the complement factor H (CFH) Tyr402His polymorphism with early and advanced age-related macular degeneration (AMD) in independent non-Hispanic White, clinic-based, case-control studies. These studies suggest the CFH His402 allele is a major risk allele in early and advanced AMD, explaining 43% to 70% of all AMD in older adults. We utilized a population-based case-control study design of early AMD among Latinos/Hispanics to evaluate the CFH Tyr402His polymorphism for an association with early AMD phenotypes. DESIGN: Retrospective population-based case-control study. PARTICIPANTS: This study cohort consists of 285 early AMD cases and 570 controls matched on age, birthplace, and smoking status. METHODS: Genotype determination was performed by allele-specific digestion of polymerase chain reaction products. MAIN OUTCOME MEASURES: Complement factor H Tyr402His polymorphism. RESULTS: We observed no overall statistically significant association with early AMD among Latinos. However, a subset of early AMD cases that have bilateral, not unilateral, intermediate-to-large soft macular drusen were 1.7 times more likely to carry either the homozygous or heterozygous His402 genotype. CONCLUSIONS: Our data suggest that the CFH Tyr402His is not a major risk factor for overall early AMD in this Latino population, but may play a role in susceptibility to phenotypes of early AMD likely to progress to late AMD.
Authors: Farzana Choudhury; Rohit Varma; Roberta McKean-Cowdin; Ronald Klein; Stanley P Azen Journal: Am J Ophthalmol Date: 2011-06-16 Impact factor: 5.258
Authors: Nicole A Restrepo; Kylee L Spencer; Robert Goodloe; Tiana A Garrett; Gerardo Heiss; Petra Bůžková; Neal Jorgensen; Richard A Jensen; Tara C Matise; Lucia A Hindorff; Barbara E K Klein; Ronald Klein; Tien Y Wong; Ching-Yu Cheng; Belinda K Cornes; E-Shyong Tai; Marylyn D Ritchie; Jonathan L Haines; Dana C Crawford Journal: Invest Ophthalmol Vis Sci Date: 2014-09-09 Impact factor: 4.799
Authors: Rohit Varma; Athena W P Foong; Mei-Ying Lai; Farzana Choudhury; Ronald Klein; Stanley P Azen Journal: Am J Ophthalmol Date: 2010-05 Impact factor: 5.258
Authors: Stephen G Schwartz; Anita Agarwal; Jaclyn L Kovach; Paul J Gallins; William Cade; Eric A Postel; Gaofeng Wang; Juan Ayala-Haedo; Kylee M Spencer; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott Journal: Retina Date: 2012-09 Impact factor: 4.256
Authors: Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein Journal: JAMA Ophthalmol Date: 2013-03 Impact factor: 7.389
Authors: Bareng A S Nonyane; Dorothea Nitsch; John C Whittaker; Reecha Sofat; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher Journal: Invest Ophthalmol Vis Sci Date: 2009-12-30 Impact factor: 4.799